Emerging infectious diseases · 2022 · 57 citations · 6 references
Veterinary MedicineImmunologyInfectious DiseasesMolecular VirologyVaccinologyVirologyAntibody CharacterizationSerological DiagnosticsSeroprevalence StudiesVaccinationVaccine DevelopmentViral VaccinesCoronavirus VaccinesInfectious Disease VaccinesLongitudinal SeroprevalenceSars-cov-2 InfectionSerial SeroconversionSeroconversion RatesSerological DetectionViral Seroprevalence
E stimating the incidence of infections caused by SARS-CoV-2 that are frequently asymptomatic is challenging when using routine passive surveillance methods. Antibodies can provide a record of previous infection, whether symptomatic or asymptomatic, and serologic surveys that measure antibodies across populations are routinely used for a variety of pathogens and are believed to provide key insights into the epidemiology and transmission of SARS-CoV-2 (1-3). However, antibody contraction and seroreversion (loss of previously documented antibodies) may lead to false-negative results, a potential issue as we move into the third year of the SARS-CoV-2 pandemic (4).
6
Age-specific mortality and immunity patterns of SARS-CoV-2
Megan O’Driscoll, Gabriel Ribeiro dos Santos, Lin Wang et al. · Nature · 2020 · 1.3K citations · Full text
Veterinary Medicine, Infectious Diseases, Epidemiologic Methods +16
Kristie E.N. Clarke, Jefferson M. Jones, Yangyang Deng et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 323 citations · Full text
Jackie Kleynhans, Stefano Tempia, Nicole Wolter et al. · Emerging infectious diseases · 2021 · 107 citations · Full text
Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +13